• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中性粒细胞与淋巴细胞比值是转移性胃癌患者的独立预后因素。

The Neutrophil to Lymphocyte Ratio is an Independent Prognostic Factor in Patients with Metastatic Gastric Cancer.

作者信息

Musri Fatma Yalcin, Mutlu Hasan, Eryilmaz Melek Karakurt, Salim Derya Kivrak, Gunduz Seyda, Coskun Hasan Senol

机构信息

Departments of Medical Oncology, Akdeniz University School of Medicine, Turkey E-mail :

出版信息

Asian Pac J Cancer Prev. 2016;17(3):1309-12. doi: 10.7314/apjcp.2016.17.3.1309.

DOI:10.7314/apjcp.2016.17.3.1309
PMID:27039764
Abstract

Inflammation can play an important role in cancer progression and the prognostic importance of neutrophil to lymphocyte ratio (NLR), a marker of inflammation, in cancer is a current investigation topic. In the present study, we aimed to determine whether there is a prognostic link between NLR and metastatic gastric cancer (mGC). A total of 143 patients from the Akdeniz University and Antalya Training and Research Hospital database were retrospectively analyzed. The median NLR value was 3.34. The median overall survival (OS) and median progression-free survival (PFS) were 11.6 and 7.9 months, respectively, in patients with NLR<3.34 while these values were 8.3 and 6.2 months respectively in patients with NLR >3.34 (p<0.001 and p=0.011, respectively). Our study showed that increased NLR is an independent prognostic factor associated with short survival in patients with mGC.

摘要

炎症在癌症进展中可发挥重要作用,中性粒细胞与淋巴细胞比值(NLR)作为一种炎症标志物,其在癌症中的预后重要性是当前的研究课题。在本研究中,我们旨在确定NLR与转移性胃癌(mGC)之间是否存在预后关联。对来自阿克德尼兹大学和安塔利亚培训与研究医院数据库的143例患者进行了回顾性分析。NLR的中位数为3.34。NLR<3.34的患者中位总生存期(OS)和中位无进展生存期(PFS)分别为11.6个月和7.9个月,而NLR>3.34的患者这些值分别为8.3个月和6.2个月(分别为p<0.001和p=0.011)。我们的研究表明,NLR升高是mGC患者生存时间缩短的一个独立预后因素。

相似文献

1
The Neutrophil to Lymphocyte Ratio is an Independent Prognostic Factor in Patients with Metastatic Gastric Cancer.中性粒细胞与淋巴细胞比值是转移性胃癌患者的独立预后因素。
Asian Pac J Cancer Prev. 2016;17(3):1309-12. doi: 10.7314/apjcp.2016.17.3.1309.
2
Application of platelet/lymphocyte and neutrophil/lymphocyte ratios in early diagnosis and prognostic prediction in patients with resectable gastric cancer.血小板/淋巴细胞比值和中性粒细胞/淋巴细胞比值在可切除胃癌患者早期诊断及预后预测中的应用
Cancer Biomark. 2015;15(6):899-907. doi: 10.3233/CBM-150534.
3
Preoperative Neutrophil to Lymphocyte Ratio as a Prognostic Factor in Patients with Non-metastatic Renal Cell Carcinoma.术前中性粒细胞与淋巴细胞比值作为非转移性肾细胞癌患者的预后因素
Asian Pac J Cancer Prev. 2015;16(9):3703-8. doi: 10.7314/apjcp.2015.16.9.3703.
4
Prognostic Value of Baseline Neutrophil-Lymphocyte and Platelet-Lymphocyte Ratios in Local and Advanced Gastric Cancer Patients.基线中性粒细胞与淋巴细胞比值及血小板与淋巴细胞比值在局部及进展期胃癌患者中的预后价值
Asian Pac J Cancer Prev. 2015;16(14):5933-7. doi: 10.7314/apjcp.2015.16.14.5933.
5
Prognostic implication of antitumor immunity measured by the neutrophil-lymphocyte ratio and serum cytokines and angiogenic factors in gastric cancer.中性粒细胞与淋巴细胞比值、血清细胞因子及血管生成因子检测的抗肿瘤免疫在胃癌中的预后意义
Gastric Cancer. 2017 Mar;20(2):254-262. doi: 10.1007/s10120-016-0613-5. Epub 2016 May 5.
6
The relationship between platelet-lymphocyte ratio, neutrophil-lymphocyte ratio, and survival in metastatic gastric cancer on firstline modified docetaxel and cisplatinum plus 5 Fluorourasil Regimen: A single institute experience.一线多西他赛联合顺铂加5-氟尿嘧啶方案治疗转移性胃癌中血小板-淋巴细胞比值、中性粒细胞-淋巴细胞比值与生存的关系:单中心经验
Saudi J Gastroenterol. 2015 Sep-Oct;21(5):320-4. doi: 10.4103/1319-3767.166207.
7
Prognostic value of preoperative neutrophils to lymphocytes ratio in patients resected for gastric cancer.术前中性粒细胞与淋巴细胞比值对胃癌切除患者的预后价值。
Am J Surg. 2015 Feb;209(2):333-7. doi: 10.1016/j.amjsurg.2014.06.014. Epub 2014 Aug 5.
8
Neutrophil-lymphocyte ratio is associated with prognosis in patients who underwent potentially curative resection for gastric cancer.中性粒细胞与淋巴细胞比值与接受胃癌根治性切除患者的预后相关。
J Surg Oncol. 2018 Apr;117(5):851-857. doi: 10.1002/jso.25036. Epub 2018 Mar 6.
9
Assessment of Prognostic Value of "Neutrophil to Lymphocyte Ratio" and "Prognostic Nutritional Index" as a Sytemic Inflammatory Marker in Non-small Cell Lung Cancer.“中性粒细胞与淋巴细胞比值”和“预后营养指数”作为非小细胞肺癌全身炎症标志物的预后价值评估
Asian Pac J Cancer Prev. 2015;16(9):3997-4002. doi: 10.7314/apjcp.2015.16.9.3997.
10
The Platelet-to-Lymphocyte Ratio Versus Neutrophil-to-Lymphocyte Ratio: Which is Better as a Prognostic Factor in Gastric Cancer?血小板与淋巴细胞比值与中性粒细胞与淋巴细胞比值:哪一个作为胃癌预后因素更具优势?
Ann Surg Oncol. 2015 Dec;22(13):4363-70. doi: 10.1245/s10434-015-4518-z. Epub 2015 Mar 25.

引用本文的文献

1
Pretreatment neutrophil-to-lymphocyte ratio predicts the benefit of gastric cancer patients with systemic therapy.治疗前中性粒细胞与淋巴细胞比值可预测接受全身治疗的胃癌患者的获益。
Aging (Albany NY). 2021 Jul 10;13(13):17638-17654. doi: 10.18632/aging.203256.
2
Neutrophil-to-lymphocyte ratio as a predictive or prognostic factor for gastric cancer treated with nivolumab: a multicenter retrospective study.中性粒细胞与淋巴细胞比值作为纳武单抗治疗胃癌的预测或预后因素:一项多中心回顾性研究
Oncotarget. 2018 Oct 2;9(77):34520-34527. doi: 10.18632/oncotarget.26145.
3
Pre-treatment Peripheral Neutrophil-Lymphocyte Ratio as a Prognostic Marker in Gastric Cancer.
治疗前外周血中性粒细胞与淋巴细胞比值作为胃癌的预后标志物
J Gastrointest Cancer. 2019 Dec;50(4):763-768. doi: 10.1007/s12029-018-0144-x.
4
The Prognostic Role of the Change in Neutrophil-to-Lymphocyte Ratio During Neoadjuvant Chemotherapy in Patients with Muscle-Invasive Bladder Cancer: A Retrospective, Multi-Institutional Study.中性粒细胞与淋巴细胞比值变化在肌层浸润性膀胱癌患者新辅助化疗中的预后作用:一项回顾性多机构研究
Bladder Cancer. 2018 Apr 26;4(2):185-194. doi: 10.3233/BLC-170133.
5
Clinicopathological and prognostic significance of high circulating lymphocyte ratio in patients receiving neoadjuvant chemotherapy for advanced gastric cancer.新辅助化疗治疗晚期胃癌患者高循环淋巴细胞比率的临床病理和预后意义。
Sci Rep. 2018 Apr 18;8(1):6223. doi: 10.1038/s41598-018-24259-5.